Your browser doesn't support javascript.
loading
Evaluating the Construct of Damage in Systemic Lupus Erythematosus.
Johnson, Sindhu R; Gladman, Dafna D; Brunner, Hermine I; Isenberg, David; Clarke, Ann E; Barber, Megan R W; Arnaud, Laurent; Fortin, Paul R; Mosca, Marta; Voskuyl, Alexandre E; Manzi, Susan; Aranow, Cynthia; Askanase, Anca; Alarcón, Graciela S; Bae, Sang-Cheol; Costedoat-Chalumeau, Nathalie; English, Jessica A; Pons-Estel, Guillermo J; Pons-Estel, Bernardo A; Gilman, Rebecca; Ginzler, Ellen M; Hanly, John G; Jacobsen, Soren; Kalunian, Kenneth; Kamen, Diane L; Lambalgen, Chynace; Legge, Alexandra; Lim, S Sam; Mak, Anselm; Morand, Eric F; Peschken, Christine A; Petri, Michelle; Rahman, Anisur; Ramsey-Goldman, Rosalind; Reynolds, John A; Romero-Diaz, Juanita; Ruiz-Irastorza, Guillermo; Sanchez-Guerrero, Jorge; Svenungsson, Elisabet; Touma, Zahi; Urowitz, Murray; Vinet, Evelyne; van Vollenhoven, Ronald F; Waldhauser, Heather; Wallace, Daniel J; Zoma, Asad; Bruce, Ian N.
Afiliación
  • Johnson SR; Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western and Mount Sinai Hospitals, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Gladman DD; Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Brunner HI; Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
  • Isenberg D; University College London Centre for Rheumatology, London, UK.
  • Clarke AE; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Barber MRW; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Arnaud L; Centre National de Reference des Maladies Autoimmunes et Systemique Rares, INSERM UMR-S 1109, Université de Strasbourg, Strasbourg, France.
  • Fortin PR; Centre de Recherche du Centre Hospitalier Universitaire de Québec, Faculté de Médecine de l'Université Laval and Centre ARThrite, Quebec City, Quebec, Canada.
  • Mosca M; University of Pisa, Pisa, Italy.
  • Voskuyl AE; Amsterdam UMC, VUmc, Amsterdam, The Netherlands.
  • Manzi S; Allegheny Health Network, Lupus Center of Excellence, Pittsburgh, Pennsylvania.
  • Aranow C; Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York.
  • Askanase A; Columbia University Irving Medical Center, New York, New York.
  • Alarcón GS; The University of Alabama at Birmingham School of Medicine.
  • Bae SC; Hanyang University Hospital for Rheumatic Diseases and Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.
  • Costedoat-Chalumeau N; Cochin Hospital, Université Paris Descartes-Sorbonne Paris Cité, and INSERM U 1153, Center for Epidemiology and Statistics Sorbonne Paris Cité, Paris, France.
  • English JA; Medical University of South Carolina, Charleston.
  • Pons-Estel GJ; Grupo Oroño, Centro Regional de Enfermedades Autoinmunes y Reumáticas, Sanatorio Parque, Rosario, Argentina.
  • Pons-Estel BA; Grupo Oroño, Centro Regional de Enfermedades Autoinmunes y Reumáticas, Sanatorio Parque, Rosario, Argentina.
  • Gilman R; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
  • Ginzler EM; SUNY Downstate Health Sciences University, Brooklyn, New York.
  • Hanly JG; Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada.
  • Jacobsen S; Copenhagen Lupus and Vasculitis Clinic, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Kalunian K; University of California San Diego School of Medicine, La Jolla.
  • Kamen DL; Medical University of South Carolina, Charleston.
  • Lambalgen C; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Legge A; Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada.
  • Lim SS; Emory University School of Medicine, Atlanta, Georgia.
  • Mak A; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Morand EF; Monash University, Melbourne, Victoria, Australia.
  • Peschken CA; Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Petri M; Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Rahman A; University College London Centre for Rheumatology, London, UK.
  • Ramsey-Goldman R; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Reynolds JA; Institute of Inflammation and Ageing, University of Birmingham and Sandwell and West Birmingham National Health Service Trust, Birmingham, UK.
  • Romero-Diaz J; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Ruiz-Irastorza G; Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, UPV/EHU, Barakaldo, País Vasco, Spain.
  • Sanchez-Guerrero J; University Health Network, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada, and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Svenungsson E; Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
  • Touma Z; Institute of Health Policy, Management and Evaluation, Toronto Western and Mount Sinai Hospitals, University of Toronto, Toronto, Ontario, Canada.
  • Urowitz M; Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western and Mount Sinai Hospitals, Toronto, Ontario, Canada.
  • Vinet E; McGill University Faculty of Medicine, Montreal, Quebec, Canada.
  • van Vollenhoven RF; Amsterdam University Medical Centres, Duivendrecht, Noord-Holland, The Netherlands.
  • Waldhauser H; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Wallace DJ; Cedars-Sinai Medical Center/David Geffen School of Medicine Center at UCLA, Los Angeles, California.
  • Zoma A; University Hospital Hairmyres, Lanarkshire, Scotland, UK.
  • Bruce IN; Manchester University Hospitals National Health Service Foundation Trust, NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester, Greater Manchester, UK, Centre for Epidemiology Versus Arthritis, Faculty of Biology, Medicine and Health, The
Arthritis Care Res (Hoboken) ; 75(5): 998-1006, 2023 05.
Article en En | MEDLINE | ID: mdl-34962100
ABSTRACT

OBJECTIVE:

The Systemic Lupus International Collaborating Clinics (SLICC), American College of Rheumatology (ACR), and the Lupus Foundation of America are developing a revised systemic lupus erythematosus (SLE) damage index (the SLICC/ACR Damage Index [SDI]). Shifts in the concept of damage in SLE have occurred with new insights into disease manifestations, diagnostics, and therapy. We evaluated contemporary constructs in SLE damage to inform development of the revised SDI.

METHODS:

We conducted a 3-part qualitative study of international SLE experts. Facilitated small groups evaluated the construct underlying the concept of damage in SLE. A consensus meeting using nominal group technique was conducted to achieve agreement on aspects of the conceptual framework and scope of the revised damage index. The framework was finally reviewed and agreed upon by the entire group.

RESULTS:

Fifty participants from 13 countries were included. The 8 thematic clusters underlying the construct of SLE damage were purpose, items, weighting, reversibility, impact, time frame, attribution, and perspective. The revised SDI will be a discriminative index to measure morbidity in SLE, independent of activity or impact on the patient, and should be related to mortality. The SDI is primarily intended for research purposes and should take a life-course approach. Damage can occur before a diagnosis of SLE but should be attributable to SLE. Damage to an organ is irreversible, but the functional consequences on that organ may improve over time through physiological adaptation or treatment.

CONCLUSION:

We identified shifts in the paradigm of SLE damage and developed a unifying conceptual framework. These data form the groundwork for the next phases of SDI development.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Reumatología / Lupus Eritematoso Sistémico Tipo de estudio: Qualitative_research Límite: Humans Idioma: En Revista: Arthritis Care Res (Hoboken) Asunto de la revista: REUMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Reumatología / Lupus Eritematoso Sistémico Tipo de estudio: Qualitative_research Límite: Humans Idioma: En Revista: Arthritis Care Res (Hoboken) Asunto de la revista: REUMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Canadá
...